Navigation Links
Paul Marks prize recognizes 3 young cancer researchers
Date:9/28/2009

ome Atlas (TCGA) project, which was initiated by the National Cancer Institute in 2006 to improve the understanding of the molecular basis of cancer. Last fall, he was one of two lead authors of TCGA's first major paper, a comprehensive characterization of the genes and pathways that are important in glioblastoma brain tumors. Finally, Dr. Meyerson's laboratory has developed a new approach to find cancer-causing microbes.

"With the ongoing revolution in genome technology, we need complete characterization of the cancer genome and all the genetic alterations that cause cancer," Dr. Meyerson said. "We're at a point where it's possible, and this goal is very much in sight."

"Matthew's findings have changed the treatment of adenocarcinomas of the lung," said James D. Griffin, Chairman of the Department of Medical Oncology at Dana-Farber, who nominated Dr. Meyerson for the prize. "This work and his ongoing work characterizing other genomic changes in lung cancers have placed him at the forefront of developing personalized therapy for patients with this deadly disease."

Dr. Meyerson received his MD degree from Harvard Medical School and his PhD degree from Harvard University.

David Sabatini

Dr. Sabatini is an associate professor of biology at the Massachusetts Institute of Technology and a member of the Whitehead Institute for Biomedical Research. He is also an HHMI investigator. While he was still in graduate school, Dr. Sabatini identified the mTOR protein kinase, a key protein in regulating cell growth, proliferation, and survival. He has continued to study the protein and its signaling pathway for much of his career, characterizing other related proteins and helping to determine how the mTOR pathway relates to cancer.

"All cells, including cancer cells, need to generate mass and ramp up production of all of their components in order to grow and divide," Dr. Sabatini explained. "We now know that mTOR is the maste
'/>"/>

Contact: Kathleen Gibson
gibsonk@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Pelosi Remarks at the Congressional Black Caucus Foundations Annual Legislative Conference
2. Regence BlueShield Receives Top Marks in Insurance Survey
3. Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform
4. Hard Rock International Marks 10 Years Of Support For Breast Cancer Awareness And Research With 2009 PINKTOBER(TM) Campaign Featuring Melissa Etheridge, The Bangles, Melanie C, Joss Stone And More
5. Pennsylvanias Clean Indoor Air Act Marks One Year Anniversary
6. Pelosi, Reid Remarks at Press Availability Following Meeting With President Obama
7. Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index
8. Minneapolis-based CornerHouse Marks 20th Anniversary of Helping Sexually Abused Children Around the World
9. Pennsylvania Patient Safety Authority Marks Milestone With One Million Reports
10. Pelosi, Democratic Leaders Remarks Today at News Conference on Legislative Accomplishments
11. Western Wayne Family Health Center -- Taylor Dedication Ceremony Marks Important Step in Providing Healthcare to Underinsured and Uninsured
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 22, 2014 Isabel Healthcare ... Health Professions (ASAHP) Conference on October 22-24 in Las ... participate in a panel discussion on Technology in Health ... Healthcare provides a diagnostic decision support tool and clinical ... skills of students and clinical learners. The Isabel tools ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 The ... , which is dedicated to distribute health information ... healthcare delivery worldwide announced the development of six ... patients expect when receiving healthcare. These are an ... patient-centered care: “providing care that is respectful of ...
(Date:10/22/2014)... Healthcare professionals who are looking for ... home or on-the-go via laptops, tablets or mobile ... premium Seminar-on-Demand CE courses. The new courses add ... hours of CE course offerings, allowing therapy ... such a diverse library, there’s something for everyone. ...
(Date:10/22/2014)... 2014 Akeso Biomedical, Inc. , ... treatment of bacterial infections, microbial biofilms, and chronic wounds, ... board of directors. , Dr. Sinskey ... The Massachusetts Institute of Technology, or MIT. He has ... Dr. Sinskey also holds positions as Co-Director of the ...
(Date:10/22/2014)... By Maureen Salamon ... -- A crucial part of conventional in vitro fertilization (IVF) ... can instead take place in a device inside the vagina, ... Colombia contend that the device, called an INVOcell, might sharply ... could also make the technology more accessible to those who ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... of world,s biological manufacturing capacity is in Puerto Rico, ... the world,s,biotechnology manufacturing capacity is located in Puerto Rico, ... Over the past four years, more than $4 ... such giants as Eli Lilly, Amgen, Abbot,Ortho Biologics, BD ...
... jobs that require them to be physically active may be ... be at a decreased risk of developing prostate cancer, according ... studied more than 2,100 men who worked at the Rocketdyne ... exposed to radiation and chemicals that may have increased their ...
... Feb. 12 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. (TSX: ... company,s,business direction in light of the recent decision from ... the FDA, PreMD today filed a request for ... with the following Code of Federal Regulations 21,CFR part ...
... Brings Significant Healthcare Leadership Experience to CTG,s Board, ... ), an,international information technology (IT) staffing and solutions company,today ... McGuire, a,healthcare executive who has served as CEO of ... a Director of CTG. Most recently,Mr. McGuire served from ...
... N.J., Feb. 12 TeamStaff, Inc.,(Nasdaq: ... and administrative,staffing services, announced today that it ... division, RS Staffing Services, Inc., to TeamStaff,Government ... Georgia based subsidiary currently provides medical, office,administration ...
... YUCAIPA, Calif., Feb. 12 Ingen Technologies,Inc. (OTC ... the signed distribution agreement with Progressive International,Holding Co. ... Taiwan, People,s,Republic of China, Japan and Korea. Please ... Progressive International Holding Company (PIHK),( http://www.pgiholding.com ) and ...
Cached Medicine News:Health News:Opportunities to Invest in Puerto Rico as Global Center for Biotechnology 2Health News:Men who are continually active at work may have a decreased risk of prostate cancer 2Health News:Men who are continually active at work may have a decreased risk of prostate cancer 3Health News:PreMD Initiates FDA Review Process and Provides Corporate Update 2Health News:PreMD Initiates FDA Review Process and Provides Corporate Update 3Health News:CTG Names William D. McGuire a Director 2Health News:CTG Names William D. McGuire a Director 3Health News:TeamStaff Renames Subsidiary to Reflect Expanding Government Services 2Health News:TeamStaff Renames Subsidiary to Reflect Expanding Government Services 3Health News:Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor 2Health News:Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor 3
(Date:10/22/2014)... CITY, Calif., Oct. 21, 2014 Abaxis, Inc. ... manufacturing point-of-care blood analysis systems, today reported financial results ... Second quarter overview: , Revenues of ... , Diluted EPS of $0.24, up 33% over ... , Service revenues from Abaxis Veterinary Reference Laboratories (AVRL) ...
(Date:10/22/2014)... 22, 2014 InVivo Therapeutics Holdings Corp. (OTCQB: ... is revolutionizing spinal cord injury (SCI) treatment with their ... outperform in tissue regrowth in the spinal cord area ... an FDA approved polymer, the scaffold ultimately breaks down ... the human body. NVIV has recently attracted significant investor ...
(Date:10/22/2014)... AUSTIN, Texas , Oct. 22, ... today announced they have entered into a license ... designed to target cancers. PhosImmune possesses ... on the surfaces of tumor cells in association ... derived from proteins that play a role in ...
Breaking Medicine Technology:Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2
... Scientists at Osel Inc . and the ... way to prevent HIV infection by genetically enhancing the ... transmission. Bioengineered bacteria introduced into the vaginal cavity of ... HIV (SHIV) by nearly two thirds. The ...
... NEW YORK, July 18, 2011 NeoStem, Inc., (NYSE-Amex: ... and sell shares of its common stock and warrants in an ... offering will be sold by NeoStem. The offering is subject to ... or when the offering may be completed, or as to the ...
Cached Medicine Technology:Scientists Use Live Bacteria to Fight HIV 2Scientists Use Live Bacteria to Fight HIV 3NeoStem Announces Proposed Public Offering of Common Stock 2NeoStem Announces Proposed Public Offering of Common Stock 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard crankshaft-type 1/1 (mm), opening width 7.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 7.0 mm and length 10 mm....
Medicine Products: